Critical Diagnostics Critical Diagnostics
Critical Diagnostics was founded in 2004 and is focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases . The lead product, the PresageĀ® ST2 Assay , has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure...   Read More
Close filters
 
from to
  •  
Aspect Reader
Aspect Reader
Heart failure progresses primarily through fibrosis and adverse remodeling as a result of cardiac injury or stress. ST2 is a biomarker that, unlike natriuretic peptides or troponin, uniquely reflects this pathway. ST2 changes rapidly...
CHF5,750.00 *